Categories AlphaGraphs, Earnings, Energy

Halliburton Company (HAL) Q3 earnings meet estimates, revenues miss

Halliburton Company (NYSE: HAL) reported in-line earnings for the third quarter of 2019. Meanwhile, revenues declined and missed the Street view. The company’s stock dropped modestly during Monday’s pre-market session, after the announcement.

Halliburton (HAL) reports stronger-than-expected Q3 results

Total revenues declined 10% year-over-year to $5.6 billion and missed the estimates, mainly hurt by the continuing weakness in North American operations. Net income attributable to the company was $295 million, or $0.34 per share, compared to $435 million, or $0.50 per share, in the year-ago period.

Earnings Beat

Adjusted net income totaled $303 million or $0.35 per share. Earnings matched analysts’ consensus estimate. The results were negatively impacted by the muted top-line performance and lower margins.

Related: Schlumberger makes modest gains post Q3 results

Completion and Production revenues slipped 16% annually to $3.51 billion, while Drilling and Evaluation revenue rose 2% to $2.04 billion.

Revenue Break-up

Region-wise, revenues in North America dropped 21% annually to $2.95 billion, while Latin American revenues rose 16% to $608 million. At $832 million, revenues at Europe, Africa and CIS ware up 10% year-over-year. Middle East/Asia revenue was broadly flat at $1.16 billion.

CEO Jeff Miller said, “International revenue, which was flat sequentially, was up 10% year to date and we remain confident that we will achieve high single-digit international growth for all of 2019. International growth continues across multiple regions, benefitting both our Drilling and Evaluation and Completion and Production divisions.”

Outlook

Going forward, the management expects to leverage the international recovery and improvement in the North American Market and generate strong free cash flow and produce strong returns.

Also see: Halliburton Q2 2019 Earnings Call Transcript

Shares of Halliburton slipped to a ten-year low last week and traded below the $20-mark, continuing the downturn that started more than a year ago. The stock closed the last trading session lower.

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top